CBD vs. Melatonin for Sleep: Which Makes Sense?

CBD and melatonin address different questions

The original version of this article promised five reasons CBD was better than melatonin. Current evidence does not support that conclusion. A useful comparison should ask what kind of sleep problem is present, how strong the evidence is for that situation and what risks matter to the individual.

Neither column identifies a universal winner. The “right” choice may be neither product, particularly when insomnia is chronic, breathing is disrupted, a medication is causing wakefulness or daytime sleepiness creates a safety risk.

Melatonin may help when the body clock is the problem

Your brain normally releases melatonin in response to darkness. The hormone helps coordinate circadian rhythms, including the timing of sleep. A supplement can shift that timing under some conditions, which is different from simply making every person sleepy on demand.

NCCIH reports that melatonin may help with jet lag and delayed sleep-wake phase disorder. Timing matters: taking it at the wrong point in the circadian cycle may be unhelpful or shift sleep in an unwanted direction. Evidence is weaker for treating chronic insomnia broadly. NCCIH cites American Academy of Sleep Medicine and American College of Physicians guidance finding insufficient strong evidence to recommend melatonin for chronic insomnia.

Short-term use appears relatively safe for many adults, but long-term safety is less certain. Reported effects include headache, dizziness, nausea and sleepiness. Older adults may experience longer-lasting effects. Pregnancy, breastfeeding, childhood use, epilepsy and blood-thinning medicine require professional guidance.

Quality also varies. NCCIH summarizes testing that found many melatonin supplements did not contain the labeled amount, and some contained serotonin. A familiar ingredient name is not proof of accurate manufacturing.

CBD-only sleep evidence remains preliminary

CBD is widely marketed for relaxation and sleep, yet marketing volume is not evidence quality. The FDA has approved one purified prescription CBD drug for specific seizure disorders;not for insomnia. Retail tinctures and gummies can also differ substantially from the high doses, controlled formulations and monitoring used in clinical research.

A small 2024 pilot randomized 30 people with moderate-to-severe primary insomnia to 150 mg nightly CBD or placebo for two weeks. The study was useful for feasibility but too small and short to establish a dependable treatment effect. A separate randomized crossover study published in 2025 involved 125 people and tested 300 mg CBD combined with eight terpenes. Its primary formulation was not ordinary CBD alone, the dose was much higher than many retail servings, and industry-affiliated authors disclosed financial interests.

A 2025 systematic review and meta-analysis of randomized studies found that CBD-only interventions did not significantly improve subjective sleep quality compared with placebo, even though some cannabinoid interventions showed benefit. That distinction is essential: results from THC-containing or mixed-cannabinoid products should not be reassigned to CBD.

CBD can also cause drowsiness, changes in alertness, gastrointestinal effects and drug interactions. Feeling sedated is not the same as restoring healthy sleep architecture or treating the cause of insomnia.

Different sleep complaints require different first steps

Cognitive behavioral therapy for insomnia is not just generic sleep-hygiene advice. It is a structured treatment that may include stimulus control, sleep scheduling, cognitive work and relapse prevention. It can be delivered in person or through validated programs. Persistent insomnia often improves more when the maintaining pattern is addressed than when nightly sedation becomes the only strategy.

Both options can affect alertness and interact with medicines

Do not drive, operate equipment or make safety-critical decisions when either product leaves you sleepy, dizzy or slowed. The FDA specifically warns that products containing cannabis-derived compounds, including CBD, can make driving dangerous because CBD may cause sleepiness and changes in alertness. Melatonin may also cause daytime drowsiness, particularly when dose or timing does not fit the user.

CBD can affect how some medicines are metabolized. Combining it with alcohol or drugs that slow brain activity can increase sedation and injury risk. Melatonin may interact with medicines as well; NCCIH specifically advises medical supervision for people with epilepsy or taking blood thinners. A product that contains CBD, CBN, melatonin and herbs creates a combination question, not four independent ingredient questions.

Use Mood’s CBD medication-interaction guide to prepare for that conversation. Never stop or change a prescribed medicine because of information on a retail website.

Verify what the product actually contains

For melatonin, look for the amount per serving, directions, other active ingredients and credible independent verification. More milligrams are not automatically better. Because supplement content can differ from the label, avoid treating a front-panel number as a laboratory measurement.

For CBD, identify isolate, broad-spectrum or full-spectrum extract; CBD and THC per serving; other cannabinoids; melatonin or botanicals; and the batch lot. Match that lot to a current certificate of analysis covering cannabinoid potency and relevant contaminants. Read Mood’s CBD COA guide for a field-by-field check.

A lawful hemp label does not guarantee zero THC, zero drug-test risk or zero next-day effect. A full-spectrum sleep product may contain CBD, CBN and trace THC, while another may add melatonin. Compare formulas ingredient by ingredient rather than attributing the entire experience to CBD.

Run a careful, time-limited sleep trial

Before adding a product, record sleep for one week. Track bedtime, estimated time to fall asleep, nighttime awakenings, final wake time, time out of bed, naps, caffeine, alcohol and next-day functioning. This baseline shows whether a later change is meaningful.

Keep a consistent wake time and obtain morning light when practical. Reserve the bed for sleep, reduce late caffeine and allow enough time for a full night. These measures are not cures for every disorder, but they reduce noise around the experiment.

Persistent or dangerous sleep symptoms need evaluation

Seek prompt, qualified clinical care when insomnia occurs at least several nights per week and persists, causes significant distress, or impairs work, school, relationships or driving. Loud snoring, witnessed pauses in breathing, gasping, morning headaches and severe daytime sleepiness can indicate sleep apnea. Uncomfortable urges to move the legs, acting out dreams or sudden sleep attacks also deserve evaluation.

Get urgent help for suicidal thoughts, severe confusion, breathing difficulty, collapse or an accidental ingestion by a child. In the United States, call or text 988 for a mental-health crisis and contact Poison Control at 1-800-222-1222 for a possible exposure.

Bring the exact package, ingredient panel, lot number and medication list to the appointment. A clinician can distinguish a circadian problem, chronic insomnia, medication effect, breathing disorder or another condition more reliably than a supplement quiz.

Sources and editorial review